« Back to Record
Rescigno, P., Dolling, D., Conteduca, V., Rediti, M., Bianchini, D., Lolli, C., Ong, M., Li, H., Omlin, A., Schmid, S., Caffo, O., Zivi, A., Pezaro, C. C., Morley, C., Olmos, D., Romero-Laorden, N., Castro, E., Saez, M. I., Mehra, N., Smeenk, S., Sideris, S., Gil, T., Banks, P., Sandhu, S. S., Sternberg, C. N., De Giorgi, U., & De Bono, J. S. (2019). Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis. European Urology Oncology. doi:10.1016/j.euo.2019.06.008
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/291318



